Geron Corporation (GERN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Geron Corporation (GERN) is down 12.1% since the beginning of the year. At $1 per share, GERN is trading 42.3% below its 52-week high of $2. Investors who bought $1,000 worth of GERN shares 5 years ago would now be looking at an investment worth $835.

Geron Corporation (GERN) has returned -12.12% so far this year and -26.11% over the past 12 months. Over the last ten years, GERN has returned -8.94% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Jul 31, 1996, GERN's average daily return is +0.12%, while the average monthly return is +2.22%. At this rate, an investment would double in approximately 2.6 years.

Historically, 46% of months were positive and 54% were negative. The best month was Mar 2003 with a return of +213.0%, while the worst month was Sep 2018 at -69.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.

On a daily basis, GERN closed higher 44% of trading days. The best single day was Mar 18, 2003 with a return of +142.8%, while the worst single day was Sep 27, 2018 at -62.9%.

Geron Corporation has an annualized alpha of 18.61%, beta of 1.23, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 01, 1996.

• This stock participated in 154.29% of S&P 500 Index downside but only 98.12% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GERN ranks 20 for risk / return — below 20% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Geron Corporation (GERN) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Geron Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Geron Corporation was 98.73%, occurring on Mar 18, 2020. The portfolio has not yet recovered.

The current Geron Corporation drawdown is 98.34%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Geron Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Geron Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.